跳至主要内容
临床试验/NCT04909931
NCT04909931已完成不适用

Vitamin D Supplementation on Outcome and Disease Activity in Rheumatoid Arthritis Patients At Rajavithi Hospital : a Randomized Clinical Trial

Rajavithi Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
To study efficacy of vitamin D on disease activity RA patients at Rajavithi hospital

研究概览

简要总结

To study efficacy of Vitamin D on outcome and disease activity ; DAS28-ESR in Rheumatoid arthritis patients at Rajavithi hospital .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 yrs old
  • RA diagnosed by ACR/EULAR 2010
  • low to moderate disease activity
  • on stable NSAIDs and DMARDs for at least 1 month
  • Received Prednisolone less than or equal to 7.5 mg/day
  • serum calcium, phosphorus and ALP are within normal limit.

排除标准

  • Chronic kidney disease stage 3 or higher
  • History of TB
  • History of Chronic liver disease
  • Pregnancy or breast-feeding
  • adjustment of immuno-suppressive drugs, steroid
  • other connective tissue disease
  • Vitamin D allergy
  • received other drugs which have vitamin D component
  • serum Vitamin D less than 10 ng/mL

研究组 & 干预措施

vitamin D supplementation group

Experimental

First arm ; add on vitamin D 40,000 IU/week for 12 weeks

干预措施: Vitamin D 2 (Drug)

second arm

Experimental

add on placebo

干预措施: Placebo (Drug)

结局指标

主要结局

To study efficacy of vitamin D on disease activity RA patients at Rajavithi hospital

时间窗: 12 weeks

Determine disease activity by DAS28-ESR in relation with vitamin D supplementation.

To study efficacy of vitamin D on IL-6 in RA patients at Rajavithi hospital

时间窗: 12 weeks

DAS-28 ESR measure from swollen joint count, tender joint count, ESR and patient global assessment

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Vitamin D Supplementation on Outcome and Disease... | 临床试验